Table 1.
Characteristics of patients
| ID | Age | Sex | BSL sCr | BSL GFR | AKI Stage | Reason AKI | Peak AKIRisk | Outcome/sCr | Disease | Surgeries |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 66 | m | 11.29 | 4.5 | End Stage | IRI | 1.6 | transplantectomy dialysis (0,5 m) | CKD, HTN | cadaver KTX |
| 2 | 38 | m | 7.26 | 16.11 | End Stage | IRI | 1.86 | 3,48 (14 m) | CKD, HTN, mitral and aortic valve regurgitation | cadaver KTX |
| 3 | 66 | m | 1.4 | 56.55 | stage 3 | prerenal, hypotension, shock | 4.74 | 1,53 (19 m) | CKD, KTX, AKI, cardiomyopathy, afib | thoracotomy |
| 4 | 69 | f | 1.21 | 44.12 | stage 3 | prerenal | 8.11 | 1,37 (19 m) | CKD, aortic stenosis, CHD, HTN, NIDDM | Valve replacement, CPR, acute CABG |
| 5 | 77 | m | 1.66 | 43.14 | stage 3 | prerenal, shock | 5.86 | Death | CTEPH, hyponatremia | none |
| 6 | 70 | f | 1.77 | 31.58 | stage 3 | contrast media | 0.38 | 1,58 (12 m) | CKD, CHD, HTN, afib, IDDM, diabetic nephropathy | none |
| 7 | 73 | m | 1.3 | 64.63 | No AKI | contrast media | 3.12 | 1,26 (3 m) | HTN, mitral and aortic valve regurgitation, afib | none |
| 8 | 56 | f | unknown | unknown | stage 3 | acute hepatits B | 73 | Lost to follow up | AKI, acute hepatitis B | LTX |
| 9 | 78 | m | 8.2 | 6.79 | End Stage | tubular injury membranous GN | 18 | 5,48 (12 m) | CKD, HTX, HTN, NIDDM | none |
| 10 | 41 | m | 0.93 | 98.18 | No AKI | toxic insult | 4.08 | 1,16 (2 m) | signet ring cell carcinoma of gaster | none |
| 11 | 54 | m | 0.67 | 123.59 | No AKI | toxic insult | 2.61 | 0,52 (9 m) | Squamous cell carcinoma of the esophagus, HTN | none |
| 12 | 57 | m | 0.73 | 107.46 | No AKI | toxic insult | 2.7 | 1,04 (13 m) | hypopharyngeal carcinoma | none |
Demographics of the 12 patients depicted in Fig. 1 including age, sex, baseline GFR, stage of AKI, AKIRisk peak level during observation time, comorbidities and relevant surgeries before or during the observation period. The outcome such as follow-up creatinine levels are provided, with the months of follow-up presented in brackets. BSL sCr baseline serum creatinine in mg/dl, GFR glomerular filtration rate in ml/min, AKI acute kidney injury, sCr serum creatinine, IRI ischemia reperfusion injury, GN glomerulonephritis, CKD chronic kidney disease, HTN hypertension, KTX kidney transplantation, CHD coronary heart disease, NIDDM non-insulin dependent diabetes mellitus, CTEPH chronic thromboembolic pulmonary hypertension, afib atrial fibrillation, IDDM insulin dependent diabetes mellitus, HTX heart transplantation, CPR cardiopulmonary resuscitation, CABG coronary artery bypass graft surgery, LTX liver transplantation